Antibiotic levels and effectiveness in patients with liver cirrhosis
Part of Digestive system, Infections clinical trials.
This study measures how antibiotic drugs called beta-lactams work in people with cirrhosis (liver damage). Researchers will check antibiotic blood levels to see if standard doses are right for cirrhotic patients or need adjustment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with liver cirrhosis
- You have a bacterial infection being treated with beta-lactam antibiotics
- You have been on the antibiotic for at least 2 days
- Your kidney and liver function were tested before starting the antibiotic
- You are taking one or two beta-lactam antibiotics (not more than two)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at bacterial infections in people with cirrhosis to understand which antibiotics still work. The goal is to improve treatment for future patients with liver disease.
This study compares standard antibiotic treatment versus antibiotic choices guided by local infection tracking (epidemiological surveillance) in people with cirrhosis who have an acute worsening and likely a bacterial infection. It may help doctors choose antibiotics more accurately and safely in this high-risk situation.
This study tests a new way to detect bacteria in the fluid in your belly (ascites) to see if it can quickly diagnose a serious infection called spontaneous bacterial peritonitis (SBP) in people with cirrhosis. If you have cirrhosis and ascites, this trial may help improve how fast infections are found.
This study tests whether giving antibiotics before liver or bile duct surgery can prevent wound infections in areas where bacteria are resistant to many antibiotics. You would receive antibiotics as a preventive measure and be monitored for any surgical site infections.
This trial checks if monitoring antibiotic levels in the blood can help doctors give the right dose to liver transplant patients with serious bacterial infections. The goal is to make the treatment work better.
This study looks at the bacteria naturally living in your gut (the microbiome) to better understand liver cirrhosis. It does not test a new drug or treatment, only collects information and samples.
Hear when a new Bacterial Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.